Enstilar

Product manufactured by Leo Pharma Inc.

Application Nr Approved Date Route Status External Links
NDA207589 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Enstilar ® (Calcipotriene And Betamethasone Dipropionate) Foam Is Indicated For The Topical Treatment Of Plaque Psoriasis In Patients 12 Years And Older. Enstilar Foam Is A Combination Of Calcipotriene, A Vitamin D Analog, And Betamethasone Dipropionate, A Corticosteroid, Indicated For The Topical Treatment Of Plaque Psoriasis In Patients 12 Years And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments